- Home
- CWST vs LEGN Comparison
CWST vs LEGN Comparison
Compare CWST & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CWST | LEGN |
|---|---|---|
| Founded | 1975 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.9B |
| IPO Year | 1997 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CWST | LEGN |
|---|---|---|
| Price | $101.90 | $21.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 13 |
| Target Price | ★ $118.67 | $69.58 |
| AVG Volume (30 Days) | 1.5M | ★ 2.4M |
| Earning Date | 02-11-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 102.54 | N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $1,795,272,000.00 | $909,045,000.00 |
| Revenue This Year | $20.40 | $68.52 |
| Revenue Next Year | $7.63 | $48.63 |
| P/E Ratio | $423.04 | ★ N/A |
| Revenue Growth | 20.54 | ★ 74.75 |
| 52 Week Low | $82.22 | $21.19 |
| 52 Week High | $121.24 | $45.30 |
Technical Indicators
Market Signals| Indicator | CWST | LEGN |
|---|---|---|
| Relative Strength Index (RSI) | 67.62 | 30.29 |
| Support Level | $98.14 | $21.19 |
| Resistance Level | $101.75 | $23.24 |
| Average True Range (ATR) | 2.17 | 0.82 |
| MACD | -0.00 | 0.17 |
| Stochastic Oscillator | 89.26 | 13.37 |
Price Performance
Historical ComparisonAbout CWST Casella Waste Systems Inc.
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.